Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 360.00
Bid: 351.00
Ask: 366.00
Change: 2.00 (0.56%)
Spread: 15.00 (4.274%)
Open: 358.00
High: 360.00
Low: 358.00
Prev. Close: 358.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

8 Jun 2009 07:00

RNS Number : 4814T
City of London Investment Group PLC
08 June 2009
 



CITY OF LONDON INVESTMENT GROUP PLC

("City of London" or "the Group")

tRADING UPDATE FOR THE YEAR TO 31 MAY 2009

City of London (AIM: CLIG), a leading emerging markets asset management group, provides a trading update for the financial year ended 31 May 2009. The numbers that follow are all unaudited.

The Group has added new clients over the period despite the significant market declines. Funds under management ("FuM") were $3.50 billion (£2.17 billion) at 31 May 2009. This compares with $4.71 billion (£2.38 billion) at 31 May 2008, a decline of 26%, versus a fall of 36% in the MSCI Emerging Markets Index (MXEF) over the same period. With revenues almost entirely dollar denominated, the Group has benefitted throughout most of the period under review from the relative weakness of sterling.

A measure of the group's success in growing FuM during what most would see as an exceptionally difficult year can be found by referencing the opening and closing FuM to the index, MXEF. At 31st May 2008, the group was managing $4.7 billion, with MXEF at 1,207. The equivalent FuM re-based to the 31st May 2009 MXEF level of 773 would be $3.0 billion, so the additional $0.5 billion represents an underlying growth rate of just under 17%. Looked at in the same way, since the apparent peak of $4.95 billion in October 2007, underlying FuM have actually grown by 24%. In addition to the stated year end FuM, awarded but unfunded mandates total a further $517 million.

For the year to 31 May 2009, City of London expects that pre-tax profits will be approximately £5.4 million (2008: £10.7 million) and that profits after an anticipated tax charge of £1.6 million (29% of pre-tax profits) will be approximately £3.8 million (2008: profits of £7.1 million after a tax charge of £3.6 million, representing 34% of pre-tax profit). Basic and fully diluted earnings per share are expected to be 15.9p and 14.8p respectively (2008: 29.3p and 26.1p).

With FuM at significantly lower levels through the second and third quarters, fee income at an expected £20.3 million represents a decrease of around 19% compared to last year's £24.9 million, the fall having been cushioned by sterling weakness. That weakness however has had an adverse impact on costs, with overheads approximately 29% higher, but variable costs, which this year should form circa 46% of the total cost base (2008: 60%), fall from £9.0 million to around £6.7 million, and as a result total "administrative expenses" are expected to be £14.5 million as compared to last year's £15.0 million.

The Group's dividend policy is unchanged, based on paying dividends that are covered approximately one and a half times by full year earnings per share, but a temporary reduction in earnings cover is intended this year in recognition of exceptional market conditions, and within the context of a strong cash position and an improving outlook. An interim dividend of 5p (2007/8: 6p) was paid in March, and in line with this and based upon the customary one thirds/two thirds split, the Board is recommending a final dividend of 10p per share (2008: 13.5p), making a total for the year of 15p (2008: 19.5p), covered 1.06 times by earnings per share (2008: 1.50 times). It is relevant to note that a substantial recovery of corporation tax, not far short of £1 million, has been accrued to reflect the allowable cost of share option exercises, but that in accordance with IAS12 this credit has for the most part been taken directly to reserves. While this tax adjustment therefore provides no earnings cover, it will upon receipt increase cash cover, and the Board proposes to take this into account when considering next year's interim dividend.

In keeping with the optimism expressed at the interim stage, the Group has continued to progress organic expansion with four senior appointments during the year. In the US, a fund manager was appointed to support the first mandate for a product investing via closed end funds in developed markets, which is expected to total US$100 million once funded. To implement the Group's decision to bring its US marketing in-house and reduce third party commissions, a marketing manager has been appointed to develop our direct relationship with the consultant industry which advises institutional investors.

In the UK, a senior fund manager specialising in Asian investment was appointed to provide the expertise necessary to develop The Asian Value & Growth Fund (a spoke of the World Markets Umbrella Fund), which will invest directly in equities in Emerging Asia. This will be launched on 1 July 2009, to be marketed initially to investors in the UK, and ultimately to the Group's client base in North America. A business development manager has been appointed to support the Group's objective to further strengthen City of London's relationships in the UK and European institutional markets.

In the prior Funds Under Management Update (9 March 2009), we remained 'unfashionably optimistic' regarding our asset class. At that point MXEF was 7.5% above the low point reached in October 2008. On 29 May 2009, MXEF closed 70% above that low and, whilst we certainly remain positive regarding the long-term prospects for emerging markets relative to developed markets, we believe that the index has probably advanced at what will prove to have been an unsustainable rate. We therefore expect that there will likely be a retrenchment within the coming months.

City of London Investment Group expects to announce final full year results for the year to 31 May 2009 on 14 September 2009.

Summary and trading update

Year to 31 May

2008

2009

Funds under Management (at period end)

US$4.7bn

US$3.5bn

Turnover (plus investment income)

£25.7m

£20.4m

Administrative expenses

£15.0m

£14.5m

Profit before tax

£10.7m

£5.4m

Profit after tax

£7.1m

£3.8m

Profit per share, basic

29.3p

15.9p

Profit per share, diluted

26.1p

14.8p

Financials - consolidated income statement

Year to 31 May

£'000

2008

2009

Fee income

24,879

20,250

Interest & other

869

(393)

Finder's commission

(3,559)

(3,036)

Custody & Administration

(775)

(898)

Total net income

20,982

15,923

Costs:

Human resources

3,640

4,390

Premises

291

447

Communications & IT

838

1,506

Business development

442

386

General

826

1,053

Total costs

6,037

7,782

Operating profit

15,377

8,141

Profit-share

4,682

2,764

Pre-tax profit

10,695

5,377

Tax

(3,559)

(1,581)

Post-tax profit

7,136

3,796

Dividends *

(3,237)

(4,418)

Retained

3,904

(622)

* prior year final plus current year interim

-ends-

For further information, please visit www.citlon.co.uk or contact:

Doug Allison (Finance Director)

Simon Hudson / Andrew Dunn

City of London Investment Group PLC

Tavistock Communications

Tel: +44 (0) 20 7860 8347

Tel: +44 (0)20 7920 3150

Jeff Keating 

Tom Price / Chris Sim

Singer Capital Markets Ltd

Evolution Securities Limited

Nominated Adviser & Joint Broker

Joint Broker

Tel: +44 (0)20 3205 7500

Tel: +44 (0)20 7071 4300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTILFVERSIEIIA
Date   Source Headline
27th Mar 20234:40 pmRNSHolding(s) in Company
22nd Mar 20232:30 pmEQSHardman & Co Research on City Of London Investment Group (CLIG): Solid results in volatile markets
21st Mar 20236:04 pmRNSHolding(s) in Company
17th Mar 20235:20 pmRNSHolding(s) in Company
17th Mar 20232:15 pmRNSINTERIM DIVIDEND – US DOLLAR CONVERSION RATE
22nd Feb 20237:00 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2022
25th Jan 20238:45 amEQSHardman & Co Research on City of London Investment Group: Swings and roundabouts
20th Jan 20237:00 amRNSSIX MONTH TRADING UPDATE AND DIVIDEND DECLARATION
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Nov 20223:15 pmEQSHardman & Co Research on City Of London Investment Group: (CLIG) Solid profits in tough markets
31st Oct 20224:22 pmRNSResult of AGM
28th Oct 20225:02 pmRNSHolding(s) in Company
27th Oct 20223:17 pmRNSDirector/PDMR Shareholding
27th Oct 20223:17 pmRNSDirector/PDMR Shareholding
27th Oct 20223:15 pmRNSDirector/PDMR Shareholding
27th Oct 20223:13 pmRNSDirector/PDMR Shareholding
27th Oct 20223:12 pmRNSDirector/PDMR Shareholding
21st Oct 202211:04 amRNSFinal Dividend - US Dollar Conversion Rate
17th Oct 20227:00 amRNSFunds Under Management - 30/09/22 - Trading Update
30th Sep 20222:28 pmRNSHolding(s) in Company
20th Sep 20227:00 amRNSFinal Results
16th Sep 20224:35 pmRNSPrice Monitoring Extension
8th Aug 20227:00 amRNSHolding(s) in Company
28th Jul 20227:15 amEQSHardman & Co Research: City of London Investment Group (CLIG): Robust profits in tough markets
28th Jul 20227:00 amRNSHolding(s) in Company
19th Jul 20227:00 amRNSPRE-CLOSE TRADING UPDATE for year to 30 June 2022
27th Jun 202211:00 amRNSDirector/PDMR Shareholding
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:37 pmRNSPrice Monitoring Extension
16th May 20225:27 pmRNSHolding(s) in Company
28th Apr 202212:25 pmEQSHardman & Co Research: City of London Investment Group (CLIG) Fighting the market invasion
26th Apr 20227:00 amRNSBoard Restructure and Director retirement
26th Apr 20227:00 amRNSFunds Under Management - 31/3/22 - Trading Update
5th Apr 20224:41 pmRNSSecond Price Monitoring Extn
5th Apr 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 20226:19 pmRNSDirector/PDMR Shareholding
23rd Feb 20223:35 pmEQSHardman & Co Research: City of London Investment Group (CLIG) Confirming an excellent first half
18th Feb 20227:00 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2021
1st Feb 202211:10 amEQSHardman & Co Research: CyanConnode (CYAN) - 3Q22 update: smart meter showtime in India
20th Jan 20224:21 pmEQSHardman & Co Research: City of London Investment Group (CLIG) - You're so special!
19th Jan 20227:00 amRNSFuM 31/12/21, Trading, Dividend & Special Dividend
29th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20211:34 pmRNSDirector/PDMR Shareholding
3rd Dec 202112:18 pmRNSDirector/PDMR Shareholding
3rd Dec 202112:16 pmRNSDirector/PDMR Shareholding
3rd Dec 20219:14 amRNSHolding(s) in Company
1st Nov 20216:02 pmRNSHolding(s) in Company
27th Oct 20215:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.